Systemic corticosteroids in asthma: A call to action from World Allergy Organization and Respiratory Effectiveness Group.
Ontology highlight
ABSTRACT: Systemic corticosteroids (SCS) are a highly effective treatment for acute exacerbations and long-term symptom control in asthma. Long-term SCS use is highly prevalent across all asthma severities, occurring in over 20% of patients with severe or uncontrolled disease globally. It is now well known that exposure to both long-term and repeated acute courses of SCS is associated with a high risk of serious adverse effects (AEs), such as osteoporosis, and metabolic and cardiovascular complications, especially when prescribed onto a background of other corticosteroids. The aim of this call-to-action article, endorsed by the World Allergy Organization and the Respiratory Effectiveness Group, is to review the accumulating evidence on the burden of SCS on patients with asthma and provide an overvie
SUBMITTER: Bleecker ER
PROVIDER: S-EPMC9761384 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA